WAVE - World Association for Vaccine Education Home About Us Contact Us Legal & Privacy
Vaccine Ingredients
Amphotericin B
Chemical Analysis

Amphotericin B:C47H73NO17, a preservative (antifungal, bactericide)

MME definition - "a drug used to treat fungus infections. Known allergy to this drug prohibits use. Side effects include blood clots, blood defects, kidney problems, nausea and fever. When used on the skin, allergic reactions canoccur."  Very often a most serious acute reaction after the infusi ...more

 Documentation  View in order of
Page  1  of  5First  |  Prev  |  Next  |  Last
Scientific Literature Only

1. "$75,000 Offered for MD to publicaly Drink Vaccine Additives"
"Not surprisingly this offer has been on the table since 2001, But no brave MDs has been willing to take the toxic chemical cocktail, But they still push their injections on children dont they. Children who innocently go for their Vaccinations. With the average amount of loans for medical students now well in excess of $100,000 you might have thought some Doctor would have tried to cash in on this so they could accelerate the payment of their student loans. The additives would be the same as those contained in the Vaccines recommended for a 6-year old according to U.S. Centers for Disease Control and Prevention (CDC) guidelines, and the dose would be-body-weight calibrated. It would include, but not be limited to: Thimerosal (A mercury derivative ), Ethylene gycol ( anti freeze), Phenol ( a disinfectant dye ), Aluminum, Benzethonium chloride ( a disinfectant ), Formaldehyde ( a preservative ), Ammonium sulfate, Amphotericin. There are more additives as well, YUMMY, Come on Doctors I want to watch the Chugging of this toxic shake. On August 1 2007, If no Brave syringe weilding pill pushing white coat maniac has accepted this offer, its getting upped to $90,000 and will increase at a rate of $5,000 per month intil a Doctor accepts. "
No Author, SunValleyOnline.com -- 7/22/2007

2. "Amphotericin B-Induced Severe Hypertension in a Young Patient: Case Report and Review of the Literature"
"Severe hypertension may be an adverse event associated with AmB treatment that requires intensive treatment."
Arrais Rodrigues, Celso, et al, Renal Failure, Volume 28, Number 2, pp. 185-187(3) -- 1/1/2006

3. "Fatal fat embolism following amphotericin B lipid complex injection."
"A case of amphotericin B lipid complex induced fatal fat embolism is described."
Tolentino LF, et al., Exp Mol Pathol. ;77(3):246-8. -- 12/1/2004

4. "Amphotericin B and liver function."
"The therapeutic potential of amphotericin B is limited due to its side effects. …Experimental data suggest that the drug may interfere with the hepatic cytochrome P450 and may thus influence the metabolic capacity of the liver."
Inselmann G, et al, Eur J Intern Med. Aug;13(5):288-292. -- 8/1/2002

5. "Amphotericin B-induced hepatorenal failure in cystic fibrosis"
"We report on a 9-year-old girl with cystic fibrosis who developed fulminant renal and hepatic dysfunction following a short course of intravenous amphotericin B for a suspected aspergillus infection, although she did not have clinical evidence of invasive aspergillosis."
Uthara R. Mohan, MB, BS, DCH, MRCP, MRCPCH, et al, Pediatric Pulmonology Volume 33, Issue 6, Pages 497 – 500 -- 5/3/2002

6. "Amphotericin B nephrotoxicity."
"In conclusion, amphotericin B nephrotoxicity is observed frequently."
Deray G, J Antimicrob Chemother; 49 Suppl 1:37-41. -- 2/1/2002

7. "The epidemiology of nephrotoxicity associated with conventional amphotericin B therapy"
"Results: Overall, 139 (28%) patients experienced renal toxicity, including 58 (12%) with moderate-to-severe nephrotoxicity."
Stephan Harbarth MD, MS, et al, The American Journal of Medicine Volume 111, Issue 7, Pages 528-534 -- 11/1/2001

8. "Mortality and Costs of Acute Renal Failure Associated with Amphotericin B Therapy"
"… the associated mortality is high when acute renal failure occurs following amphotericin B therapy."
D. W. Bates, et al, Clinical Infectious Diseases 2001; 32:686-693 -- 1/1/2001

9. "Correlates of acute renal failure in patients receiving parenteral amphotericin B"
"Background: While parenteral amphotericin B is an effective therapy for serious fungal infections, it frequently causes acute renal failure (ARF). .. Acute renal failure occurred in a quarter of the patients."
David W Bates, et al, Kidney International (2001) 60, 1452–1459; doi: 10.1046/j.1523-1755.2001.00948.x -- 1/1/2001

10. "Severe Hepatic Injury Associated with Lipid Formulations of Amphotericin B"
"A 14-year-old girl with leukemia had Doppler ultrasound evidence of hepatic necrosis, thought to be caused by a lipid formulation of amphotericin B"
M. Ellis, et al, Clinical Infectious Diseases, volume 32 (2001), pages e87–e89 -- 1/1/2001


Page  1  of  5First  |  Prev  |  Next  |  Last

 

 


  WAVE - Common Menu
Navigate
Learn About
  Specific Vaccines
  Reactions / Conditions
  Vaccine Risks
  Vaccine Ineffectiveness
  Vaccine Ingredients
  How? Why?
  Authorities Speak Out
  Law / Exemptions

Communicate
  Vaccine Blog
  Receive Newsletter
  Send to a Friend
  News and Views

Contribute
  Take a Stand
  Add to the Database
  Testimonials
  Link to WAVE
  Donate